問題一覧
1
Sidenadil, Vardenafil, Tadalafil, Avanafil
2
Mechanism of action for PDE-5 Inhibitors
3
Sildenafil and Vardenafil
4
Vardenafil
5
Vardenafil ODT; Vardenafil-coated oral tablet
6
Tadalafil
7
Avanafil
8
PDE-5 Inhibitors
9
Avanafil and daily dose Tadalafil
10
PDE5-Inhibitors
11
PDE-5 Inhibitors
12
Vardenafil
13
PDE-5 Inhibitors
14
Tadalfil
15
Drug-drug interactions of PDE-5 Inhibitors
16
Sildenafil, Vardenafil, and Tadalafil
17
Sildenafil and Tadalafil
18
PGE-5 Inhibitors
19
PDE-5 Inhibitors
20
PDE-5 Inhibitors
21
Vardenafil
22
PDE-5 inhibitors
23
Alprostadil
24
Prostaglandin E1 (PGE1)
25
Pharmacokinetics of Prostaglandin E1 (PGE1)
26
Adverse Drug Effects of Prostaglandin E1 (PGE1)
27
Alpha-adrenergic antagonists
28
Mechanism of Action of Alpha-adrenergic antagonists
29
Well absorbed by oral administration. Doxazosin, Afluzosin, Tamsulosin, and Silodosin are metabolized through the cytochrome P450 system. Silodosin is a substrate for P-glycoprotein. Terazosin is metabolized by the liver but not through the CYP system. The half-life is 8-22 hours with a peak of 1-4 hours
30
Severe Renal Dysfunction
31
Dizziness, fatigue, nasal congestion, headache, drowsiness, orthostatic hypotension. Drugs that are selective for its receptor have an increased incidence of retrograde ejaculation or the ability to ejaculate. “Floppy Iris Syndrome” during cataract eye surgery.
32
Doxazosin, Alfuzosin, Tamsulosin, and Silodosin
33
Decrease plasma concentrations of Alpha-adrenergic antagonists
34
Alfuzosin
35
P-gp (cyclosproine)
36
Tamsulosin, Alfuzosin, and Silodosin; Doxazosin and Terazosin
37
Silodosin
38
Finasteride and Dutasteride
39
Inhibition of 5 alpha-reductase which converts testosterone to dihydrotestosterone (DHT). DHT is an androgen that stimulates prostate growth. By reducing DHT, the prostate shrinks, and urine flow improves, but in order to be effective the prostate must be enlarged. It takes several months for the drug to be effective. Both drugs can also treat alopecia.
40
These drugs can be taken with food. Both drugs are highly protein bound and metabolized by the CYP450 system. The mean plasma elimination half-life of Finasteride is 6-16 hours, while the terminal elimination half-life of Dutasteride is 5 weeks once steady-state is achieved (typically after 6 months of therapy).
41
Adverse Drug Effects of 5 alpha-reductase inhibitors
42
5 alpha-reductase inhibitors
43
Comination therapy (5-alpha reductase inhibitor + alpha-adrenergic antagonists)
44
Block the degredation of cGMP in the corpus cavernosum
45
Nitroglycerin
46
Used as an alternative for patients who are not candidates for oral therapies for ED
47
Alpha-(a1) receptor
48
Silodosin
49
Alprostadil
50
Start Tamsulosin and continue Finasteride
51
Tadalafil
52
Avanafil
53
Inhibits 5-alpha-reductase
54
2 and 3
55
Urge incontinence and bladder overactivity
56
Oxybutynin
57
Duration of Action
58
Leads to a prolonged erection [>4 hours]
59
Enhance effect of nitric oxide
60
Isosorbide
61
Associated with birth defects
62
Dizziness
63
Stress incontinence; Refer to urologist for biofeedback to assist with Kegel exercises; Refer to urologist for consideration of periurethral bulking agents
64
PDE-5 Inhibitors
65
Testosterone because the drugs inhibit the conversion of testosterone to DHT
66
PGE-5 Inhibitors
67
Doxazosin, Alfuzosin, Tamsulosin, and Silodosin
68
Decrease plasma concentrations of Doxasozin, Alfuzosin, Tamulosin, and Silodosin
August 2019 Special PE Exam
August 2019 Special PE Exam
ユーザ名非公開 · 93問 · 13日前August 2019 Special PE Exam
August 2019 Special PE Exam
93問 • 13日前薬学
薬学
ユーザ名非公開 · 15問 · 1ヶ月前薬学
薬学
15問 • 1ヶ月前CRM Y FISIOLOGÍA DE VUELO SKYVIP
CRM Y FISIOLOGÍA DE VUELO SKYVIP
ユーザ名非公開 · 50問 · 2ヶ月前CRM Y FISIOLOGÍA DE VUELO SKYVIP
CRM Y FISIOLOGÍA DE VUELO SKYVIP
50問 • 2ヶ月前TOXICOLOGY
TOXICOLOGY
ユーザ名非公開 · 77問 · 2ヶ月前TOXICOLOGY
TOXICOLOGY
77問 • 2ヶ月前Spelling test 4 - hypo hyper logy
Spelling test 4 - hypo hyper logy
ユーザ名非公開 · 10問 · 2ヶ月前Spelling test 4 - hypo hyper logy
Spelling test 4 - hypo hyper logy
10問 • 2ヶ月前OTHER GLANDS
OTHER GLANDS
ユーザ名非公開 · 8問 · 2ヶ月前OTHER GLANDS
OTHER GLANDS
8問 • 2ヶ月前SEX GLANDS
SEX GLANDS
ユーザ名非公開 · 35問 · 2ヶ月前SEX GLANDS
SEX GLANDS
35問 • 2ヶ月前PARATHYROID GLAND
PARATHYROID GLAND
ユーザ名非公開 · 12問 · 2ヶ月前PARATHYROID GLAND
PARATHYROID GLAND
12問 • 2ヶ月前THYROID GLAND
THYROID GLAND
ユーザ名非公開 · 71問 · 2ヶ月前THYROID GLAND
THYROID GLAND
71問 • 2ヶ月前PITUITARY GLAND PART 2
PITUITARY GLAND PART 2
ユーザ名非公開 · 5問 · 2ヶ月前PITUITARY GLAND PART 2
PITUITARY GLAND PART 2
5問 • 2ヶ月前M11c15
M11c15
مقطع من الاغاني عراقيه قصيره · 13問 · 2ヶ月前M11c15
M11c15
13問 • 2ヶ月前nstp
nstp
ユーザ名非公開 · 25問 · 4ヶ月前nstp
nstp
25問 • 4ヶ月前PHARMA
PHARMA
JHAYS · 13問 · 4ヶ月前PHARMA
PHARMA
13問 • 4ヶ月前LEUKOPOIESIS II AND MONOPOIESIS MCQ
LEUKOPOIESIS II AND MONOPOIESIS MCQ
Jef Marc Valencia · 39問 · 4ヶ月前LEUKOPOIESIS II AND MONOPOIESIS MCQ
LEUKOPOIESIS II AND MONOPOIESIS MCQ
39問 • 4ヶ月前Clearance
Clearance
Almira Coleen · 24問 · 4ヶ月前Clearance
Clearance
24問 • 4ヶ月前BLOOD COLLECTION
BLOOD COLLECTION
Jef Marc Valencia · 35問 · 4ヶ月前BLOOD COLLECTION
BLOOD COLLECTION
35問 • 4ヶ月前chapter 2
chapter 2
ユーザ名非公開 · 10問 · 4ヶ月前chapter 2
chapter 2
10問 • 4ヶ月前chapter 2
chapter 2
ユーザ名非公開 · 10問 · 4ヶ月前chapter 2
chapter 2
10問 • 4ヶ月前LYMPHOPOIESIS
LYMPHOPOIESIS
Jef Marc Valencia · 44問 · 4ヶ月前LYMPHOPOIESIS
LYMPHOPOIESIS
44問 • 4ヶ月前Types of Microorganisms and Their Characteristics
Types of Microorganisms and Their Characteristics
HERSHEY VALERIE BERNARDINO · 39問 · 4ヶ月前Types of Microorganisms and Their Characteristics
Types of Microorganisms and Their Characteristics
39問 • 4ヶ月前問題一覧
1
Sidenadil, Vardenafil, Tadalafil, Avanafil
2
Mechanism of action for PDE-5 Inhibitors
3
Sildenafil and Vardenafil
4
Vardenafil
5
Vardenafil ODT; Vardenafil-coated oral tablet
6
Tadalafil
7
Avanafil
8
PDE-5 Inhibitors
9
Avanafil and daily dose Tadalafil
10
PDE5-Inhibitors
11
PDE-5 Inhibitors
12
Vardenafil
13
PDE-5 Inhibitors
14
Tadalfil
15
Drug-drug interactions of PDE-5 Inhibitors
16
Sildenafil, Vardenafil, and Tadalafil
17
Sildenafil and Tadalafil
18
PGE-5 Inhibitors
19
PDE-5 Inhibitors
20
PDE-5 Inhibitors
21
Vardenafil
22
PDE-5 inhibitors
23
Alprostadil
24
Prostaglandin E1 (PGE1)
25
Pharmacokinetics of Prostaglandin E1 (PGE1)
26
Adverse Drug Effects of Prostaglandin E1 (PGE1)
27
Alpha-adrenergic antagonists
28
Mechanism of Action of Alpha-adrenergic antagonists
29
Well absorbed by oral administration. Doxazosin, Afluzosin, Tamsulosin, and Silodosin are metabolized through the cytochrome P450 system. Silodosin is a substrate for P-glycoprotein. Terazosin is metabolized by the liver but not through the CYP system. The half-life is 8-22 hours with a peak of 1-4 hours
30
Severe Renal Dysfunction
31
Dizziness, fatigue, nasal congestion, headache, drowsiness, orthostatic hypotension. Drugs that are selective for its receptor have an increased incidence of retrograde ejaculation or the ability to ejaculate. “Floppy Iris Syndrome” during cataract eye surgery.
32
Doxazosin, Alfuzosin, Tamsulosin, and Silodosin
33
Decrease plasma concentrations of Alpha-adrenergic antagonists
34
Alfuzosin
35
P-gp (cyclosproine)
36
Tamsulosin, Alfuzosin, and Silodosin; Doxazosin and Terazosin
37
Silodosin
38
Finasteride and Dutasteride
39
Inhibition of 5 alpha-reductase which converts testosterone to dihydrotestosterone (DHT). DHT is an androgen that stimulates prostate growth. By reducing DHT, the prostate shrinks, and urine flow improves, but in order to be effective the prostate must be enlarged. It takes several months for the drug to be effective. Both drugs can also treat alopecia.
40
These drugs can be taken with food. Both drugs are highly protein bound and metabolized by the CYP450 system. The mean plasma elimination half-life of Finasteride is 6-16 hours, while the terminal elimination half-life of Dutasteride is 5 weeks once steady-state is achieved (typically after 6 months of therapy).
41
Adverse Drug Effects of 5 alpha-reductase inhibitors
42
5 alpha-reductase inhibitors
43
Comination therapy (5-alpha reductase inhibitor + alpha-adrenergic antagonists)
44
Block the degredation of cGMP in the corpus cavernosum
45
Nitroglycerin
46
Used as an alternative for patients who are not candidates for oral therapies for ED
47
Alpha-(a1) receptor
48
Silodosin
49
Alprostadil
50
Start Tamsulosin and continue Finasteride
51
Tadalafil
52
Avanafil
53
Inhibits 5-alpha-reductase
54
2 and 3
55
Urge incontinence and bladder overactivity
56
Oxybutynin
57
Duration of Action
58
Leads to a prolonged erection [>4 hours]
59
Enhance effect of nitric oxide
60
Isosorbide
61
Associated with birth defects
62
Dizziness
63
Stress incontinence; Refer to urologist for biofeedback to assist with Kegel exercises; Refer to urologist for consideration of periurethral bulking agents
64
PDE-5 Inhibitors
65
Testosterone because the drugs inhibit the conversion of testosterone to DHT
66
PGE-5 Inhibitors
67
Doxazosin, Alfuzosin, Tamsulosin, and Silodosin
68
Decrease plasma concentrations of Doxasozin, Alfuzosin, Tamulosin, and Silodosin